Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Thursday, July 2, 2026

Snapshot: Jul 2, 2026 · 6:00 PM 100 stocks analyzed

Strong Up Day

Thu, Jul 2, 2026 Complacency High

Broad rally with tech lagging and fear evaporating—SPY +1.7%, small caps down, but single-stock chaos dominates as VIX plunged 12% and Financial Services surged.

55% Complacency settled in as the VIX crashed 12.3% on a strong up day, signaling investors abandoned fear despite a bifurcated market where SPY climbed 1.7% but Russell 2000 and NASDAQ 100 both slipped, leaving breadth question marks beneath a calm-tape surface.
30% Financial Services dominated gainers (45% of top 50) led by blockbuster M&A moves—CLRO's 101% merger announcement with Cortigent, CWD's 90% blockchain expansion, and structural buyback programs from YRD (+59%) and PPCB (+23%)—while the sector's size and cash richness powered the session's upside breadth.
15% Extreme dispersion exposed high single-stock turbulence with 50 gainers averaging +24% and 50 losers averaging -23.9%, anchored by news-grounded stories like ELTX's -37% dilution plunge, NCRA's -34% reverse-split warning, and five debutants (SURG, CMMB, SDEV, MINE, TENX) returning to top gainers after long absences.

Financial Services drove 45% of gainers 5 names returned after long absences SURG — first appearance CMMB — first appearance

Market Regime

Thu, Jul 2, 2026 Neutral conf: low macro · prototype

+23

Tailwind −100 … +100 · + tailwind / − headwind

VIX16.2 Drawdown-1.7% Held1d · nascent SinceJul 2

Top drivers: Small-cap leadership ▲ VIX 5d momentum ▲ S&P drawdown (60d) ▲

processId: history-market-regime

Market Indexes

Thu, Jul 2, 2026 13

S&P 500

7,483.24

+125.75

+1.71%

Dow Jones

52,900.07

+979.45

+1.89%

NASDAQ Composite

25,832.67

+474.07

+1.87%

NASDAQ 100

29,329.21

−111.11

-0.38%

DJ US Total Market

74,314.56

+1,203.42

+1.65%

Russell 1000

4,084.45

+74.26

+1.85%

S&P MidCap 400

3,802.81

−19.44

-0.51%

Russell 2000

2,996.11

−11.75

-0.39%

Russell 2500

1,274.47

−5.04

-0.39%

Russell 3000

4,268.21

+73.54

+1.75%

Nasdaq Financial-100

7,406.57

+360.95

+5.12%

NIFTY 50

24,175.70

+229.45

+0.96%

VIX

16.15

−2.26

-12.28%

Biggest Gainers

Thu, Jul 2, 2026 50

CLRO

ClearOne, Inc.Technology

$6.48+$3.26

+101.2%

NASDAQ · Mkt cap $13 M

ClearOne announced a definitive merger agreement with Cortigent, a subsidiary of Vivani Medical, which will result in a name and ticker change to Cortigent Holdings (CRGT). This transformational M&A event triggered a 101% single-day surge.

The merger announcement itself is the clear catalyst. ClearOne shareholders are receiving a deal that will result in the company being acquired and relisted under a new corporate structure and name. A 101% gain on the announcement day is consistent with M&A-driven re-rating, particularly if the market views the transaction as accretive, if it resolves prior uncertainty, or if it unlocks value that was previously discounted in the stock. The merger was announced simultaneously by both companies on July 2, 2026, providing full transparency on the terms and structure. Without access to the full merger agreement details, we cannot assess whether the terms are favorable relative to the pre-deal valuation, but the market's immediate response of doubling the stock price suggests investors view the deal favorably or see it as resolution of prior distress.

CWD

CaliberCos Inc.Financial Services

$1.23+$0.58

+90.6%

NASDAQ · Mkt cap $4.6 M

Caliber announced expansion of its blockchain strategy, integrating Chainlink infrastructure for tokenized private real estate funds, which catalyzed a 90% jump in CWD stock on strong investor enthusiasm for the blockchain initiative.

The sole headline provided reports Caliber's announcement of the next phase of its blockchain strategy, specifically integrating Chainlink infrastructure to support tokenized private real estate funds. This is a concrete corporate development that directly addresses investor interest in blockchain and tokenization trends. The timing of the announcement on 2026-07-02 aligns with the stock's 90% intraday surge, and the headline notes the stock jumped "over 110%" according to the news outlet, which matches closely with the 90.61% move reported in the snapshot. The announcement appears to constitute a material strategic pivot or expansion that likely resonated with investors focused on blockchain exposure and alternative asset tokenization. No earnings, earnings guidance changes, or other financial performance data are mentioned in the headline.

YRD

Yiren Digital Ltd.Financial Services

$1.44+$0.54

+59.7%

NYSE · Mkt cap $102 M

Yiren Digital announced a new $20 million share repurchase program on July 2, which likely drove the 59.68% intraday surge as buyback announcements often signal management confidence and reduce share count.

The headlines establish that Yiren Digital announced a $20 million share repurchase program using its cash balance on July 2, 2026. This is a concrete corporate action that directly preceded the stock's jump to the 3 biggest gainer position. Share buybacks are typically interpreted by markets as a positive signal of undervaluation and management confidence, and they mechanically reduce share count, which can support earnings per share. The timing—announcement at 09:35 UTC followed by a "Why Is YRD Stock Surging?" headline at 11:13 UTC on the same day—strongly links cause to effect. The broader sector update mentioning financial stocks advancing provides context but is secondary to the company-specific catalyst. No conflicting news or negative developments are present in the provided headlines.

DSY

Big Tree Cloud Holdings LimitedConsumer Defensive

$4.47+$1.59

+55.2%

NASDAQ · Mkt cap $18 M

No news headlines were found in the last 48 hours for DSY, so the 55% surge on July 2, 2026 cannot be attributed to a documented corporate announcement or market event. The driver remains unclear from available data.

DSY jumped 55% to rank as the fourth-largest gainer of the day, yet no news articles appeared in the Yahoo Finance RSS feed during the preceding 48 hours. This disconnect between significant price movement and absence of headline coverage suggests either a delayed news release not yet indexed by the feed, a technical catalyst such as short covering or options-related positioning, or a rumor circulating in less formal channels. Small-cap or lower-liquidity stocks like Big Tree Cloud Holdings can experience outsized moves on limited trading volume, and the lack of visible news does not rule out insider activity, analyst upgrades issued outside RSS distribution, or broker-initiated coverage. Without access to intraday events, SEC filings released on July 2 itself, or microcap trading chat communities, the true catalyst remains unknowable from the evidence at hand.

SURG

SurgePays, Inc.Communication Services

$0.57+$0.16

+38.1%

NASDAQ

SurgePays announced a restructured wholesale carrier agreement on July 1st that modernizes commercial terms, lowers subscriber costs, and strengthens the balance sheet, likely driving the 38% single-day gain.

The company released a formal press release on July 1st detailing a restructuring of its wholesale carrier agreement designed to support profitable wireless subscriber growth. The amendment specifically addresses three investor-relevant points: modernized commercial terms, reduced future subscriber acquisition costs, and balance sheet strengthening. For a micro-cap stock trading at $0.57, this kind of operational restructuring announcement—particularly one framed around improving unit economics and financial position—can trigger substantial single-day rallies, especially if investors view it as a step toward profitability or reduced cash burn. The timing of the move on July 2nd, one business day after the release, is consistent with market processing of the news. The broader market context (weak jobs data, modest equity rally) appears incidental to SURG's move.

SLBT

Horizon Space Acquisition II Corp.Healthcare

$5.99+$1.54

+34.6%

NASDAQ · Mkt cap $1.8 B

No news headlines were found in the last 48 hours, so the cause of this 34.61% jump cannot be determined from available reporting. The move may reflect a SPAC-related event, technical rebound, or undisclosed catalyst.

Horizon Space Acquisition II Corp. is a blank-check company with no news reported in the last two days to explain a jump to the 6 position among daily gainers. SPACs frequently experience sharp price moves tied to merger announcements, shareholder votes, warrant exercises, or redemption deadlines that may not immediately appear in headline feeds. Alternatively, the stock could have rebounded from oversold technical conditions, been caught in short-covering activity, or responded to a delayed announcement not yet indexed by the news source provided. Without access to SEC filings, press releases, or intraday events, the specific catalyst remains unidentified.

HLP

Hongli Group Inc.Basic Materials

$0.75+$0.19

+34.4%

NASDAQ · Mkt cap $90 M

No news headlines were found in the last 48 hours, so the 34% jump in HLP on July 2, 2026 cannot be directly attributed to a specific announcement or disclosed event.

The absence of recent news makes it difficult to pinpoint a definitive cause for the 34% intraday gain. HLP, a micro-cap stock trading at $0.75, could be responding to several common catalysts in this market segment: a delayed or unindexed corporate announcement that broke outside traditional wire services, short-covering or technical buying pressure after a previous decline, insider activity or a change in analyst coverage not yet syndicated to major RSS feeds, sector-wide momentum in its industry, or retail trading interest amplified by social media attention. Without corroborating headlines, any explanation remains speculative, though penny and micro-cap stocks are particularly prone to sharp moves driven by low liquidity and technical factors.

CMMB

Chemomab Therapeutics Ltd.Healthcare

$2.27+$0.57

+33.5%

NASDAQ · Mkt cap $15 M

No news headlines were found in the last 48 hours, so the 33.53% gain on July 2 cannot be attributed to a specific reported event. The jump likely stems from technical trading, a delayed announcement, or market rumor in a micro-cap biotech stock.

Chemomab Therapeutics is a small-cap clinical-stage biotech company, and no earnings, clinical trial results, FDA actions, partnerships, or other corporate announcements appear in the available news feeds for the past two days. This creates a gap between the magnitude of the price move and any confirmed catalyst. Micro-cap biotech stocks can experience sharp moves on limited volume driven by short covering, retail interest in penny-stock-like trading, delayed dissemination of news to major news aggregators, or unconfirmed rumors in specialized forums. Without visibility into the specific trigger, the move remains unexplained by available public information. The stock's rank as the eighth-largest gainer of the day suggests broad market interest, but the absence of corroborating headlines is noteworthy and limits confidence in attributing the move to fundamentals.

HSPT

Horizon Space Acquisition II Corp.Financial Services

$5.86+$1.42

+31.8%

SDEV

NovaBay Pharmaceuticals, Inc.Healthcare

$1.36+$0.32

+30.8%

CCTG

CCSC Technology International Holdings Limited Ordinary SharesIndustrials

$0.91+$0.20

+28.5%

NASDAQ · Mkt cap $8.8 M

No news headlines were found in the last 48 hours, so the 28.53% gain on CCTG likely stems from technical factors, unindexed announcements, or market speculation rather than a major disclosed corporate event.

The absence of any news headlines in the Yahoo Finance RSS feed for the past two days makes it difficult to identify a specific catalyst for the +28.53% jump. CCTG trades at a very low price of $0.91, which is typical of microcap and penny stocks that can experience outsized percentage moves on relatively small absolute dollar volume shifts. Stocks in this price range are often sensitive to technical bounces, short covering, retail momentum, or small undisclosed announcements that don't always appear in mainstream financial news feeds immediately. Without access to the company's investor relations page, SEC filings, or social media activity, we cannot determine whether an earnings report, partnership announcement, or regulatory update occurred but simply hasn't been indexed yet. The 11th biggest gainer ranking suggests broad market participation but does not itself explain the underlying cause.

BNRG

Brenmiller Energy LtdUtilities

$1.03+$0.22

+27.2%

LIMN

Liminatus Pharma, Inc. Class A Common StockHealthcare

$0.14+$0.03

+24.1%

NASDAQ · Mkt cap $9.4 M

Liminatus Pharma announced an amended definitive merger agreement with InnocsAI to expand its oncology cell therapy pipeline, with the transaction expected to close on July 2, 2026, the same day of this snapshot, likely driving the 24% intraday gain.

The news headline establishes that Liminatus amended its merger agreement with InnocsAI on June 30, 2026, specifically to expand the company's oncology cell therapy pipeline. The press release indicates the transaction was expected to close on July 2, 2026, which is the snapshot date provided. For a microcap biotech stock trading at $0.14, a merger closing or material transaction expansion can trigger significant single-day rallies, particularly if investors view the expanded pipeline as accretive or strategically valuable. The timing alignment between the expected close date and the snapshot date strongly suggests market participants were pricing in positive sentiment around deal finalization and the expanded oncology assets being added to Liminatus's portfolio.

PPCB

Propanc Biopharma, Inc.Healthcare

$1.77+$0.33

+22.9%

NASDAQ · Mkt cap $2.6 M

Propanc Biopharma announced a $5.0 million share repurchase program on July 2, with an initial $500,000 tranche over the next 30 days, likely driving the 22.92% single-day gain as a positive signal of management confidence and shareholder-friendly capital allocation.

The headline establishes a specific corporate action: announcement of a share buyback program totaling $5.0 million. Share repurchase programs are typically interpreted as bullish signals by the market because they suggest management believes the stock is undervalued and signal confidence in the company's prospects. The immediate 30-day $500,000 tranche provides near-term concrete commitment. For a micro-cap biotech stock trading at $1.77, buybacks can have a material impact on earnings per share and reduce share count. The timing of the announcement on market open (12:30 UTC on July 2) and the stock's rank as the 14th biggest gainer suggest this was a meaningful catalyst. No clinical trial data, FDA decisions, or partnership announcements appear in the headlines, so the move is driven primarily by financial engineering and sentiment rather than fundamental business development.

WBX

Wallbox N.V.Technology

$4.16+$0.76

+22.4%

NYSE · Mkt cap $73 M

Wallbox announced completion of an €11.8 million equity raise and secured an additional €4 million investment on July 2, triggering a 22.35% gain likely driven by positive funding news and reduced financial pressure.

On July 2, 2026, Wallbox released a press release announcing the completion of an approximately €11.8 million equity raise and an additional €4 million investment commitment. For a smaller-cap EV charging infrastructure company, capital raises of this magnitude can signal multiple positive developments: improved access to growth capital, validation from investors, and reduced near-term dilution risk if structured favorably. The timing coincides exactly with the stock's jump to 15 biggest gainer, and the news was released at 10:38 UTC, well before market close. A secondary factor is the broader premarket tech sector advance noted in the 13:11 headline, though the Wallbox-specific capital announcement is the more direct and material catalyst for such a large percentage move.

AVXX

Defiance Daily Target 2X Long AVAV ETF

$9.04+$1.60

+21.5%

NASDAQ

No news headlines are available for the past 48 hours. The 21.51% gain in AVXX likely reflects a sharp rally in its underlying holding AVAV (AeroVironment) combined with the leveraged 2X structure of this ETF, which amplifies daily price movements of the underlying stock.

AVXX is a leveraged daily target 2X long ETF tracking AeroVironment (AVAV). It has no structural reason to move independently of AVAV; rather, it systematically amplifies daily returns by roughly two times. If AVAV gained approximately 10-11% on July 2, 2026, AVXX would naturally show a gain near 20-22%, matching the observed move. Without any news headlines provided for AVXX or AVAV in the past 48 hours, the specific catalyst for AVAV's movement cannot be determined from the information given. The move could be driven by company-specific news (earnings, contract wins, guidance), sector rotation, technical factors, or market-wide movements. The absence of headlines does not mean no news occurred; it may reflect timing lags in news aggregation or the headline feed's coverage limits.

MYPS

PLAYSTUDIOS, Inc.Communication Services

$0.63+$0.11

+20.8%

NASDAQ · Mkt cap $63 M

No news headlines were found in the last 48 hours, so the 20.80% gain on MYPS cannot be directly attributed to a reported catalyst. The move likely reflects technical trading, retail interest, or an untracked announcement.

PlayStudios is a small-cap gaming and entertainment company trading at $0.63, and stocks in this category often experience outsized percentage moves on relatively low trading volume and minimal news flow. The absence of any Yahoo Finance headlines in the last 48 hours does not rule out a catalyst—news may have been published through other channels, there could be social media momentum, short covering in a thinly traded name, or a company announcement not yet indexed by the RSS feed. Small-cap stocks are also prone to technical bounces and sector rotation trades. Without confirmed news, it is impossible to establish a specific fundamental driver for this intraday gain.

MRNX

Daily Target 2X Long MRNA ETF

$55.08+$9.44

+20.7%

AMEX

No news headlines from the past 48 hours are available, but MRNX is a 2X leveraged long ETF tracking Moderna, so a ~10% move in MRNA would mechanically produce roughly a 20% move in this instrument.

The absence of recent news makes it impossible to identify a specific catalyst from headline sources. However, MRNX is a daily target 2X leveraged long ETF on Moderna stock, which means it is mathematically constructed to deliver approximately double the daily returns of its underlying asset. A ~10% gain in MRNA would naturally translate into a ~20% gain in MRNX through leverage mechanics alone, with no need for a separate news event specific to the ETF itself. The actual driver would be whatever moved Moderna shares on July 2, 2026. Possible categories include clinical trial results, pipeline updates, analyst upgrades, sector rotation favoring biotech, or broader market sentiment shifts toward Moderna specifically, but none of these can be confirmed from the available evidence.

VACH

Voyager Acquisition Corp.Financial Services

$2.07+$0.35

+20.0%

MINE

Mayfair Gold Corp.Basic Materials

$2.57+$0.41

+19.0%

FIGG

Leverage Shares 2x Long FIG Daily ETF

$19.38+$3.04

+18.6%

NASDAQ

No news headlines were available in the last 48 hours, but FIGG is a 2x leveraged long ETF on Financials (FIG), so an 18.6% gain likely reflects a sharp rally in the underlying financial sector index amplified by the fund's 2x daily reset mechanism.

No recent news headlines were found to explain the move directly. However, FIGG's structure provides a clear inference: it is a leveraged ETF with 2x daily rebalancing on the Financials Select Sector SPDR (FIG). A +18.6% one-day move in a 2x daily reset vehicle suggests the underlying financial sector index gained approximately 9-10% on July 2, which would then be doubled by the fund's leverage. Such a sharp single-day move in financials could reflect sector-wide positive catalysts—earnings beats, interest-rate expectations, M&A activity, or broad market relief rallies—but without specific headlines, the exact trigger remains unclear. The move is consistent with how leveraged ETFs amplify daily moves in their underlying index.

VRXA

Veraxa Biotech Holding AGHealthcare

$2.04+$0.32

+18.3%

NASDAQ · Mkt cap $260 M

VRXA jumped 18.26% on announcement that it has initiated cell line development for its lead BiTAC cancer therapy program in collaboration with contract research organization ATUM, a key step toward regulatory advancement.

The stock's substantial gain appears directly tied to the July 2 news that VRXA has engaged ATUM to support stable clonal cell line generation for its lead BiTAC-TCE (T-cell engager) program. This represents tangible forward progress on a lead therapeutic candidate, moving the program toward IND (Investigational New Drug) and CTA (Clinical Trial Application) enabling activities. For early-stage biotech firms, visible milestone achievement—especially partnerships with recognized CROs and advancement toward regulatory pathways—typically signals de-risking and can attract investor confidence. The duplicate news on the same date from two sources suggests this was a coordinated press release, amplifying visibility. The third headline from July 1 about antibody therapeutics sector deal activity may also have contributed to positive sector sentiment, though it is less directly tied to VRXA's specific announcement.

PLBL

Polibeli Group LtdConsumer Cyclical

$10.26+$1.58

+18.2%

NASDAQ · Mkt cap $2.2 B

No news headlines were available in the last 48 hours for PLBL, so the 18.2% jump cannot be definitively attributed to a specific catalyst. The move likely reflects technical factors, delayed news distribution, or market rumors not yet captured in major financial feeds.

The absence of recent news headlines for PLBL during a period in which the stock surged 18.2% to rank as the 23rd biggest gainer of the day is notable. This disconnect suggests the catalyst may not yet be widely reported through Yahoo Finance RSS feeds, or it may have occurred before the 48-hour window. Without specific information about PLBL's business, market cap, float, or insider ownership, it is difficult to assess whether this move reflects a technical bounce, a short squeeze, delayed earnings release, insider activity, or a rumor circulating in retail trading communities. Smaller-cap or lower-liquidity stocks on NASDAQ sometimes experience outsized daily moves on relatively low volume or information asymmetries that take time to reflect in major news outlets.

BMGL

Basel Medical Group Ltd Ordinary SharesHealthcare

$8.35+$1.26

+17.8%

NASDAQ · Mkt cap $8.1 M

No news headlines were found in the last 48 hours for BMGL, so the 17.77% gain on July 2, 2026 cannot be directly attributed to any reported company announcement or market event. The jump likely reflects either delayed news absorption, a technical or speculative catalyst, or sector momentum.

BMGL shares jumped significantly on July 2, 2026, ranking as the 24th biggest gainer of the day, yet Yahoo Finance returned no headlines in the prior 48-hour window. This disconnect between strong price action and absent news coverage suggests several possibilities. First, relevant news may have been issued but not yet picked up by the RSS feed, or it may have emerged very early on July 2 itself. Second, the move could reflect a technical bounce after prior weakness, short covering, or sector-wide momentum in medical devices or biotech. Third, an unconfirmed rumor or social media discussion could have sparked retail interest. Without access to the actual news and given BMGL's positioning as a medical device or specialty pharma stock, common catalysts in this space include clinical trial results, regulatory approvals, partnership announcements, or analyst upgrades, but none of these can be confirmed here.

COSM

Cosmos Health Inc.Healthcare

$0.24+$0.04

+17.6%

NASDAQ · Mkt cap $12 M

Cosmos Health announced the expansion of its share buyback program by an additional 770,000 shares on July 2, following the completion of an initial 2.65 million share repurchase on July 1, likely driving the +17.61% rally as buybacks reduce share count and signal management confidence.

The stock jumped 17.61% on the same day the company announced an expansion of its buyback authorization. On July 1, Cosmos Health completed an initial repurchase of 2.65 million shares for $500,000 (implying a price around $0.19 per share). The following day, July 2, management announced it had already repurchased an additional 770,000 shares and would continue open market purchases. Share buybacks mechanically reduce the outstanding share count, which can boost earnings per share and signal that management believes the stock is undervalued at current levels. This announcement of aggressive, consecutive repurchase activity likely triggered the rally. The July 1 headline mentioning the stock slumped to 52-week lows provides context that COSM had been beaten down, making the buyback announcement potentially more impactful as a reversal signal.

GETY

Getty Images Holdings, Inc.Communication Services

$0.90+$0.13

+17.4%

NYSE · Mkt cap $111 M

Getty's stock jumped 17.4% after the company walked away from its $3.7 billion Shutterstock merger on July 1st, with news on July 2nd that Getty's bonds surged 14 cents on the redemption plan, signaling improved financial flexibility and creditor confidence.

The headlines establish that Getty rejected the Shutterstock deal after UK regulators (the CMA) demanded the sale of Shutterstock's editorial business as a condition of approval. Rather than accept this structural breakup, Getty terminated the transaction. The immediate market response reflects two factors: first, equityholders no longer face the dilution or integration risk of a $3.7 billion acquisition; second, the bond market's 14-cent jump suggests creditors view the redemption of 2030 notes favorably, implying Getty has liquidity or strategic optionality post-deal. The stock's gain likely reflects relief that the deal is off the table combined with improved perceived financial standing. However, the longer-term implications for Getty's growth strategy and competitive position versus a combined entity remain unclear from the headlines provided.

BWET

Breakwave Tanker Shipping ETF

$174.29+$25.31

+17.0%

AMEX

BWET surged 17% on 2026-07-02, likely driven by broad recognition that tanker shipping ETFs were among the top-performing asset classes in the first half of 2026, as confirmed by multiple headlines highlighting shipping's dominance alongside strong earnings and geopolitical tailwinds.

The two headlines provided both reference shipping as a standout performer in 1H 2026, with the July 2 article explicitly naming shipping alongside semis as a top-performing ETF area fueled by AI, geopolitics, and strong earnings. This suggests the market was recognizing or reaffirming tanker shipping's outperformance on the final trading day of the half. However, the headlines do not identify a specific catalyst on July 2 itself—no earnings announcement, no contract award, no geopolitical event, and no guidance change tied to BWET or its underlying holdings. The move appears to reflect cumulative sector momentum and possibly year-end rebalancing into outperforming areas rather than a discrete news event. Tanker ETFs are typically sensitive to freight rates, trade flows, and vessel supply-demand dynamics, all of which may have tightened in the first half, but none of these factors are detailed in the headlines provided.

SOXS

Direxion Daily Semiconductor Bear 3X ETF

$4.51+$0.65

+16.8%

AMEX

No semiconductor-related news appeared in the last 48 hours, but SOXS is a 3X inverse leveraged ETF that gains when semiconductor stocks fall sharply, so a major selloff in chip stocks on or before July 2 likely drove this 16.84% jump.

No headlines were found in the last 48 hours to explain the move directly. However, SOXS is a Direxion Daily Semiconductor Bear 3X leveraged inverse ETF, meaning it is designed to deliver three times the inverse daily return of the Semiconductor Index. A +16.84% gain in SOXS implies the underlying semiconductor index fell approximately 5.6% that day (before leverage effects). This is consistent with a significant broad selloff in chip stocks, which could stem from macroeconomic concerns, disappointing earnings or guidance from major semiconductor companies, geopolitical risk affecting the sector, or broader equity market weakness. Without specific news headlines, the catalyst remains undetermined, but sector weakness rather than company-specific news is the structural driver.

CLVT

Clarivate PlcTechnology

$2.59+$0.37

+16.7%

NYSE · Mkt cap $1.3 B

No news headlines were found in the last 48 hours to explain Clarivate's 16.67% gain on July 2, 2026, suggesting the move may be driven by technical factors, delayed announcements, or market sentiment shifts rather than a fresh public catalyst.

The absence of recent news headlines is notable given the magnitude of the move. Clarivate is a provider of solutions in intellectual property, scientific research, and analytics. Stocks in this sector sometimes respond to delayed market reactions to earlier earnings or guidance, short covering, or technical rebounds after prior weakness. Without access to intraday commentary, premarket news, or non-headline catalysts (insider activity, analyst downgrades reversed, industry tailwinds), the specific trigger remains unclear. The 16.67% single-day gain is substantial enough that a material corporate event or market sentiment shift likely occurred, but the evidence provided does not identify it.

BIYA

Baiya International Group Inc.Technology

$0.63+$0.09

+16.6%

NASDAQ · Mkt cap $71 M

No headlines found in the last 48 hours to explain BIYA's 16.57% gain, so the catalyst remains unclear; the jump could reflect delayed news, technical trading, or market rumors not yet picked up by major feeds.

The absence of any Yahoo Finance headlines in the 48 hours preceding this move makes it impossible to attribute the 16.57% rally to a specific corporate event. For a micro-cap stock like BIYA trading at $0.63, typical catalysts include earnings releases, insider transactions, analyst initiations, or sector-wide momentum. The stock's rank as the 30th biggest gainer suggests genuine volume and interest, but without corroborating news, the underlying reason is speculation. It is possible the move reflects a delayed pickup of an announcement from earlier in the week, retail trading activity, or short-covering in a low-liquidity name. Without additional sources or company disclosures, no definitive cause can be established.

RVNL

GraniteShares 2x Long RIVN Daily ETF

$37.97+$5.37

+16.5%

NASDAQ

No news headlines available in the last 48 hours, but the 16.48% gain likely reflects a sharp rally in Rivian stock itself, which this 2x leveraged ETF amplifies by design.

RVNL is a 2x daily leveraged long ETF tracking Rivian (RIVN), meaning it delivers approximately double the daily percentage move of the underlying stock. With no news headlines surfaced in the past 48 hours, the gain cannot be attributed to a specific company announcement, product launch, earnings beat, or regulatory action affecting Rivian directly. The most likely explanation is a broad market rally, a sector-specific move in electric vehicles or automotive, or positive sentiment around Rivian from earlier announcements now being repriced. Alternatively, the move could reflect technical factors such as short covering, options-related hedging flows, or accumulation ahead of expected events. Without current headlines or data on Rivian's own stock movement, the precise catalyst remains unclear.

TENX

Tenax Therapeutics, Inc.Healthcare

$15.46+$2.17

+16.3%

NASDAQ · Mkt cap $71 M

Tenax Therapeutics rose 16.33% following announcements of a late-breaking LEVEL trial data presentation at ESC Congress 2026 and plans to report topline results in August, signaling progress in its Phase 3pipeline and generating positive investor sentiment ahead of data release.

On July 2, 2026, Tenax announced two developments: a late-breaking presentation slot for LEVEL clinical trial data at ESC Congress 2026 and confirmation that topline results would be reported in August. For a Phase 3 development-stage biotech, securing a late-breaking presentation slot is typically a positive signal suggesting meaningful or competitive interim findings, and the imminent August data announcement provides a concrete catalyst. Investors appear to have interpreted these milestones as de-risking events for a critical program. The company also announced inducement grants under Nasdaq rules, a routine matter unlikely to drive the move. The broader market opened higher on a weaker-than-expected June jobs report, providing modest tailwinds. The 16.33% gain ranks TENX as the 32nd biggest gainer of the day, suggesting the announcement resonated strongly with investors focused on clinical-stage biotech catalysts.

MERC

Mercer International Inc.Basic Materials

$0.78+$0.11

+16.1%

NASDAQ · Mkt cap $31 M

No news headlines were found in the last 48 hours, so the 16.09% gain on MERC appears driven by technical or market factors rather than a disclosed corporate event.

The absence of recent news makes it difficult to identify a specific catalyst for the 16.09% jump. Mercer International is a pulp and paper company, and stocks in this sector can be sensitive to commodity price movements, currency fluctuations, or shifts in production outlook. The move could reflect a recovery in pulp prices, an upward revision in market sentiment toward the forestry or packaging sector, short covering if the stock had been heavily shorted, or simply technical momentum and volume accumulation. Without corroborating headlines or official announcements, any explanation remains speculative. It is also possible that relevant news exists but was not captured in the Yahoo Finance RSS feed queried, or that the move is driven by intraday trading patterns rather than fundamental information.

TECX

Tectonic Therapeutic, Inc.Healthcare

$37.93+$5.19

+15.9%

TSDD

GraniteShares 2x Short TSLA Daily ETF

$7.89+$1.05

+15.4%

MSTP

GraniteShares 2x Long MSTR Daily ETF

$14.90+$1.98

+15.3%

NASDAQ

No news headlines were found in the last 48 hours, but MSTP is a 2x leveraged ETF tracking Microstrategy, so a large move in the underlying stock would be amplified approximately twofold in the fund.

The absence of any headlines in the provided news feed makes it impossible to identify a specific catalyst for today's 15.32% gain. However, MSTP is structurally designed to deliver twice the daily return of its underlying asset, Microstrategy (MSTR). This means if MSTR moved up roughly 7-8% today, MSTP would naturally amplify that to approximately 15%, which aligns with the observed price action. The actual driver would be whatever moved MSTR—whether that was a corporate announcement, Bitcoin price movement (given Microstrategy's significant Bitcoin holdings), market sentiment shift, or technical trading. Without access to MSTR-specific news or market data, we cannot determine which of these categories caused the move, only that the leverage mechanism is working as designed.

MSTX

Daily Target 2X Long MSTR ETF

$9.83+$1.30

+15.2%

NASDAQ

No headlines were found in the last 48 hours, but MSTX is a 2X leveraged long ETF on MicroStrategy (MSTR), so a +15.24% jump likely reflects a significant rally in the underlying stock, amplified by the fund's 2X leverage structure.

Yahoo Finance reported no news headlines in the last 48 hours for MSTX itself. However, this security is a daily target 2X long leveraged ETF tracking MicroStrategy (MSTR). The +15.24% gain is consistent with the underlying MSTR stock moving approximately +7.6% to +7.8% on the day, which the 2X leverage then amplifies to roughly the observed result. The cause of the move resides in MSTR's price action, not MSTX-specific news. Without headlines on either MSTX or MSTR provided here, the driver could stem from several common catalysts for MicroStrategy: movements in Bitcoin or crypto holdings, changes in the company's capital allocation strategy, debt or equity issuance announcements, or broader tech-sector sentiment. Leveraged ETFs are also susceptible to intraday volatility resets that can magnify moves, though the scale here suggests a real underlying asset move.

TSLQ

Tradr 2X Short TSLA Daily ETF

$18.68+$2.47

+15.2%

NASDAQ

No news headlines found in the past 48 hours, but TSLQ is a 2X inverse TSLA ETF that gains when Tesla stock falls sharply, suggesting Tesla experienced a significant decline on July 2, 2026.

No recent news headlines were available to explain the move directly. However, TSLQ is a leveraged inverse ETF designed to move 2X in the opposite direction of Tesla stock daily. A 15.24% gain in TSLQ would typically correspond to roughly a 7-8% decline in Tesla's stock price on the same day, assuming normal leverage mechanics held. Without access to Tesla's actual price action or news catalysts for July 2, the most likely explanations fall into standard categories: Tesla could have experienced a significant negative earnings or guidance announcement, broader market sell-off affecting growth stocks, negative commentary from analysts or executives, regulatory concerns, or competitive pressures. The absence of headlines in the RSS feed does not mean no news occurred; it may indicate delayed indexing, a technical glitch, or that the catalyst was intraday price action rather than a formal announcement.

AURA

Aura Biosciences, Inc.Healthcare

$7.74+$1.01

+15.0%

NASDAQ · Mkt cap $778 M

No news headlines were found in the last 48 hours, so the 15% gain likely reflects either a delayed market reaction to an earlier announcement, a technical or short-squeeze move, or company-specific developments not yet picked up by major news feeds.

The absence of recent headlines makes it difficult to pinpoint a specific catalyst for AURA's 15% jump on July 2, 2026. Aura Biosciences is a clinical-stage ophthalmology company focused on virus-directed oncolytic immunotherapy, so the stock typically responds to clinical trial updates, regulatory milestones, partnership announcements, or shifts in investor sentiment around its pipeline. Without news coverage in the provided 48-hour window, the move could reflect several scenarios: a delayed market digestion of an older press release, short covering, technical strength in small-cap biotech, or an announcement made through channels not captured by the RSS feed. For a micro-cap biotech stock, volume spikes and momentum trades also commonly drive outsized single-day moves independent of news.

HFFG

HF Foods Group Inc.Consumer Defensive

$1.82+$0.23

+14.5%

NASDAQ · Mkt cap $102 M

No news headlines were found in the last 48 hours for HFFG, so the 14.47% gain on July 2, 2026 likely stems from technical buying, short covering, or an untracked announcement rather than a major published story.

The absence of recent news headlines makes pinpointing the cause difficult. HFFG is a small-cap food distribution company, and stocks in this category can experience sharp single-day moves from several drivers: short squeezes or covering by small float holders, delayed earnings or operational updates not yet picked up by major feeds, insider activity or analyst upgrades released outside mainstream media channels, sector rotation into consumer staples, or technical bounce following weakness. Without access to real-time press releases, regulatory filings, or social media discussion, we cannot rule out a material event that occurred but simply was not captured in the Yahoo Finance RSS feed provided. The 14.47% move is substantial enough to suggest something catalyst-driven rather than pure noise, but the evidence is simply not available here.

LAFAR

LaFayette Acquisition Corp. Rights

$0.11+$0.01

+14.4%

NASDAQ

No news headlines found in the last 48 hours. The 14.4% gain in this SPAC rights unit is likely driven by technical trading, arbitrage activity related to the underlying warrant or common share, or delayed market reaction to prior developments.

Lafayette Acquisition Corp. Rights (LAFAR) is a special purpose acquisition company rights offering, a security that typically exhibits low absolute price volatility but can move sharply on percentage terms due to its minimal dollar price. With no relevant news in the past 48 hours, the jump is most likely attributable to one of several mechanisms common to SPAC rights: mechanical arbitrage between the rights unit and the underlying common or warrant, technical or momentum trading in a thinly traded security, or delayed market pricing of a previously announced event (such as a merger vote, business combination update, or shareholder communication) that came to light outside the 48-hour window. Without visibility into trading volume, short interest, or the status of the underlying SPAC merger process, we cannot pinpoint the catalyst more precisely.

VRAX

Virax Biolabs Group LimitedHealthcare

$3.13+$0.39

+14.2%

NASDAQ · Mkt cap $2.5 M

No news headlines were found in the last 48 hours, so the 14.23% gain on VRAX cannot be attributed to a specific announced event. The move likely reflects technical trading, short covering, or delayed market reaction to prior news.

The absence of recent headlines makes it impossible to tie this gain to a concrete catalyst like earnings, FDA approval, or a clinical update. For a small-cap biotech stock like Virax Biolabs, gains of this magnitude are not uncommon and can arise from several sources: (1) short-covering or momentum-driven technical trading, (2) delayed market reaction to news released before the 48-hour window, (3) sector-wide momentum in biotech, or (4) internal developments not yet picked up by major news wires. Without access to intraday volume data, social media chatter, or SEC filings from the past few days, it is not possible to determine which mechanism drove the move. The ranking as the 42nd biggest gainer suggests broad interest but does not clarify the underlying reason.

AIRT

Air T, Inc.Industrials

$28.87+$3.52

+13.9%

NASDAQ · Mkt cap $75 M

No news headlines appeared in the last 48 hours to explain Air T's 13.89% gain on July 2, 2026, so the catalyst remains unclear without additional context.

Air T, Inc. is a small-cap stock that jumped approximately 14% with no corresponding news coverage in the provided sources. This absence of headline support makes it difficult to pinpoint a specific catalyst. For a company of this size and trading venue, potential explanations could include a delayed or embargoed press release not yet picked up by Yahoo Finance RSS, an intraday announcement or conference activity, technical factors such as options expiration or short-covering, or accumulation driven by insider activity or analyst upgrade not yet reflected in major news feeds. Without visibility into trading volume, options positioning, or company filings released during market hours, it is difficult to distinguish between genuine fundamental news and technical/sentiment-driven movement. Small-cap stocks are also more prone to liquidity-driven gaps and individual investor activity that may not correlate with traditional news flow.

MST

Leveraged Long + Income MSTR ETF

$9.12+$1.10

+13.7%

NASDAQ

No news headlines were found in the last 48 hours, but MST's +13.72% gain is likely explained by its leveraged structure amplifying gains in the underlying Bitcoin or MSTR stock, which may have rallied on broader market or crypto momentum.

MST is a leveraged long ETF tracking MSTR (MicroStrategy), a company with significant Bitcoin holdings whose stock price correlates strongly with Bitcoin movements and tech sector sentiment. With no identified news catalyst in the provided headlines, the +13.72% jump most likely reflects either a sharp rally in the underlying MSTR stock or Bitcoin price movement, amplified by the ETF's leverage factor. Leveraged ETFs magnify daily moves of their underlying assets by a fixed multiple (typically 2x or 3x), so even a 5-7% move in MSTR could produce a 13.72% move in MST depending on its leverage ratio. Without access to MSTR's price action or Bitcoin data for the same period, we cannot pinpoint the exact source, but leverage amplification is the structural explanation that best fits the gap between the absence of breaking news and the magnitude of the move.

UPC

Universe Pharmaceuticals Inc.Healthcare

$6.32+$0.76

+13.7%

NASDAQ · Mkt cap $3.5 M

No news headlines were available in the last 48 hours to explain UPC's 13.67% gain, so the catalyst remains unclear; the move may reflect delayed news, sector momentum, technical factors, or untracked catalysts.

Yahoo Finance returned no headlines for Universe Pharmaceuticals in the preceding 48 hours, which means we cannot point to a specific earnings report, FDA decision, clinical trial result, partnership announcement, or guidance change to explain the jump. For a small-cap pharmaceutical company moving 13.67% in a single day without visible news, plausible categories include a delayed or embargoed announcement not yet indexed by RSS feeds, technical or short-covering momentum in a thinly traded stock, sector-wide tailwinds affecting smaller biotech names, or potentially an untracked press release published directly by the company. Without direct evidence, we cannot determine which of these actually drove the move.

CVKD

Cadrenal Therapeutics, Inc. Common StockHealthcare

$3.60+$0.43

+13.6%

NASDAQ · Mkt cap $5.9 M

Cadrenal announced an $8.8 million private placement on July 1st, which likely drove the 13.56% gain as investors responded positively to the cash infusion that extends the company's runway into Q1 2027.

The private placement announcement issued on July 1st (one day before the snapshot date) provides a clear catalyst for the stock's jump. Cadrenal secured $3 million upfront with up to $5.8 million in additional potential proceeds from warrant exercises, extending cash runway into the first quarter of 2027. For a small biotech or clinical-stage company, securing near-term financing is typically viewed positively by the market as it reduces bankruptcy risk and allows continued execution of the business plan. The at-the-market pricing under Nasdaq rules suggests the offering was conducted at fair value, making it less dilutive than a deeply discounted raise would have been. The timing of the announcement and price move aligns well, as the news broke on July 1st and the stock gained 13.56% by July 2nd.

MOGU

MOGU Inc.Consumer Cyclical

$2.05+$0.24

+13.3%

NYSE · Mkt cap $16 M

No news headlines were found in the last 48 hours, so the 13.26% jump in MOGU stock cannot be directly attributed to a reported event. The move likely reflects either delayed market reaction to an older announcement, technical trading, or unconfirmed market rumors.

With zero headlines covering MOGU in the last two days, we cannot point to a specific catalyst such as earnings, strategic partnership, or guidance change. MOGU Inc. is a Chinese fashion and lifestyle e-commerce platform, a sector historically sensitive to macroeconomic shifts in China, regulatory changes affecting tech companies, or shifts in consumer sentiment. The stock could have moved on technical factors such as short covering or algorithmic trading, or investors may have reacted to news not yet captured in the provided RSS feed. Without access to insider trading alerts, social media momentum, or Chinese-language financial news sources, the precise cause remains unclear.

BRCC

BRC Inc.Consumer Defensive

$1.21+$0.14

+13.1%

NYSE · Mkt cap $203 M

No news headlines are available for the past 48 hours to explain BRCC's 13% jump. The move likely reflects technical trading, a delayed announcement, or sector sentiment, but the specific catalyst is unknown.

BRC Inc. posted a significant 13.08% gain to rank 48th among daily gainers on July 2, 2026, yet no recent news appears in the Yahoo Finance RSS feed covering the prior 48 hours. This disconnect between price action and available information suggests either that the catalyst has not yet been reported through major news channels, that the move is technically driven (short covering, options-related buying, or chart-based triggers), or that a material announcement is pending disclosure. Small-cap stocks like BRCC frequently experience outsized moves on light volume, sector momentum, or delayed news dissemination. Without access to real-time trade data, company filings, or earnings surprises, we cannot identify a specific event.

GDXU

MicroSectors Gold Miners 3X Leveraged ETNFinancial Services

$95.79+$11.04

+13.0%

AMEX

No news headlines were available in the last 48 hours, but the 13% gain in this 3X leveraged gold miners ETN likely reflects a sharp rally in the underlying gold mining sector or gold prices themselves.

The absence of specific company or market news in the provided headlines makes direct cause attribution impossible. However, GDXU is a 3X leveraged ETN tracking gold mining equities, which means its daily performance is mechanically amplified relative to its underlying index. A roughly 4-5% move in the underlying gold miners index or spot gold prices would translate to approximately this 13% gain. Typical catalysts for gold miner rallies include sharp moves in the gold spot price (driven by US dollar weakness, inflation concerns, or central bank signals), broad precious metals sector rotation, or shifts in interest rate expectations. Without specific news, the cause likely lies in one of these macro factors rather than company-specific developments.

IZM

ICZOOM Group Inc.Technology

$0.37+$0.04

+13.0%

NASDAQ · Mkt cap $2.8 M

No news was reported in the last 48 hours, so the 12.99% gain on July 2nd cannot be attributed to a specific corporate announcement. The move likely reflects technical trading, short covering, or market rumors in a low-liquidity microcap stock.

The absence of any headlines in the Yahoo Finance RSS feed in the last 48 hours means we cannot tie this gain to earnings, guidance, contracts, or other fundamental catalysts. For a stock trading at $0.37 with minimal liquidity, price movements of this magnitude are common and often driven by factors outside traditional news channels. The stock's penny-stock characteristics make it susceptible to technical bounces, short squeezes, retail trading interest, or unconfirmed rumors circulating on message boards or social media. Without access to volume data, insider transactions, or short interest levels, we cannot determine which of these mechanisms likely drove the move. It is also possible that an announcement was made outside the 48-hour window but the market reacted to it on this date.

Biggest Losers

Thu, Jul 2, 2026 50

AMPGR

Amplitech Group, Inc. Series A Right

$0.91−$1.22

-57.3%

NASDAQ

No news headlines were found in the last 48 hours, but the 57% single-day collapse of a Series A Right security suggests either a triggered redemption event, an underlying business announcement, or a technical/liquidity event tied to the parent company or warrant mechanics.

The absence of news in the Yahoo Finance RSS feed does not mean no catalyst occurred; it may indicate that relevant announcements were made outside the 48-hour window, on a non-standard newswire, or that the market reaction preceded formal disclosure. Amplitech Series A Rights are equity instruments tied to a specific redemption or conversion event, and sharp declines in such securities typically reflect either (1) a triggering event that reduces the right's value or optionality, (2) deterioration in the underlying business prospects that impacts the intrinsic or time value of the right, or (3) shifts in the probability that the right will be exercised or redeemed at favorable terms. Without headlines, the most likely categories are a business setback in the parent company, a redemption or expiration milestone, or a capitalization event that diluted the right's terms.

Token Cat LimitedIndustrials

$2.93−$1.87

-39.0%

NASDAQ · Mkt cap $5.5 M

No specific news about Token Cat Limited was provided. The 39% single-day drop likely reflects broad market weakness, a company-specific event not captured in the headlines, or typical volatility for a microcap stock, but the cause cannot be determined from available evidence.

The headlines provided discuss general market movements in Asian equities and US employment data but contain no information about Token Cat Limited, its financials, operations, guidance, or any corporate action. The only market context is that US stocks were expected to open lower on Wednesday due to employment data missing forecasts and Middle East developments, but this occurred on July 1st while TC's major decline appears dated July 2nd. For a microcap stock trading at $2.93 with a 39% single-day loss, typical catalysts would include earnings surprises, insider selling, dilutive offerings, missed guidance, or short-term technical capitulation, but none of these are identified in the available news. The disconnect between TC's severity of loss and the mild negative tone in broader market headlines suggests either a company-specific announcement was not captured or the stock exhibits the kind of extreme intraday volatility common in lower-priced equities.

ELTX

Elicio Therapeutics, Inc.Healthcare

$3.22−$1.92

-37.4%

NASDAQ · Mkt cap $82 M

Elicio Therapeutics announced a $15 million registered direct offering on July 2, which likely triggered the 37% stock decline due to shareholder dilution concerns, especially following a recent trial disappointment mentioned in headlines.

The headlines establish two material facts: Elicio announced a $15 million registered direct offering on July 2, and the company experienced a "trial disappointment" weeks prior. The timing and magnitude of the stock decline (down 37% to $3.22) strongly correlates with the direct offering announcement. In biotech, registered direct offerings—particularly at depressed prices following clinical setbacks—typically trigger significant selloffs due to equity dilution and the negative signal such capital raises send about the company's cash position and confidence in its pipeline. The headline reference to "another blow" reinforces that investor sentiment was already weakened by prior trial results, making the offering announcement especially punitive. While the broader market moved higher on July 2 (as noted in the first headline about S&P opening higher), ELTX bucked that trend sharply, indicating company-specific rather than macro drivers. The offering price and terms were not disclosed in the provided headlines, so the exact dilution percentage is unknown, but biotech direct offerings at distressed valuations commonly produce single-day drops of this magnitude.

PTIX

Protagenic Therapeutics, Inc.Healthcare

$0.23−$0.13

-36.1%

NASDAQ · Mkt cap $652 K

No news headlines were published in the last 48 hours to explain PTIX's 36% drop on July 2, 2026, making the specific catalyst unknown from available sources.

The absence of recent news headlines in this 48-hour window means the reported cause of the decline cannot be directly identified from the provided evidence. For a micro-cap biotech stock trading at $0.23, sharp single-day drops of this magnitude are typically driven by one or more of these categories: negative clinical trial results, FDA regulatory setbacks, dilutive financing announcements, insider selling, short squeeze reversals, or broad sector rotation out of speculative names. Without headlines, we cannot determine which mechanism applied on this specific date. The lack of news could itself indicate that the catalyst was either announced before the 48-hour window, emerged after market close on July 1, or was internal/market-driven rather than company-initiated.

LHAI

Linkhome Holdings Inc.Real Estate

$1.76−$0.98

-35.8%

NASDAQ · Mkt cap $12 M

Linkhome announced completion of its Mortgage One Group acquisition and GPU financing business launch on July 1, but the stock plunged 35.77% the next day, suggesting market skepticism about the deal's value or integration prospects rather than enthusiasm for the expansion.

The only company-specific news in the 48-hour window is Linkhome's announcement of a completed acquisition and new business line. This is typically a positive catalyst, yet the stock fell sharply the following trading day, ranking fifth among Nasdaq losers. The disconnect suggests investors reacted negatively to details in the acquisition announcement itself—such as the purchase price, deal terms, dilution to existing shareholders, or reduced guidance—rather than celebrating the expansion. Alternatively, the market may have concerns about management's ability to integrate Mortgage One or successfully execute the GPU financing pivot. The weak macro headline about US job growth (57,000 jobs in June) is unlikely to explain a 35% drop in a single fintech stock, though broader market weakness could have amplified sector-specific selling if the acquisition news was already unpopular.

AMPGZ

Amplitech Group, Inc. Series B Right

$1.00−$0.54

-35.1%

NASDAQ

No news headlines were found in the last 48 hours, so the 35% decline in this Series B rights offering cannot be directly attributed to a specific company announcement or event from available sources.

The absence of recent news makes it impossible to pinpoint a definitive catalyst for the sharp 35% drop. However, AMPGZ is a Series B right, a derivative security tied to Amplitech Group's restructuring or capital raise. Rights offerings and warrant-like securities are highly sensitive to several factors: deterioration in the underlying parent company's stock price, shifts in investor sentiment about the company's financial health or prospects, changes in exercise prices or redemption terms, or broad market movements in the semiconductor/defense contractor sector where Amplitech operates. Without headline evidence, the decline could reflect weakness in the parent stock, reduced likelihood of successful exercise, or technical selling pressure in a lower-liquidity derivative instrument. Rights can trade with significant daily volatility independent of company news if underlying fundamentals shift or if holders reassess their intrinsic value relative to exercise economics.

NCRA

Nocera, Inc.Consumer Defensive

$0.07−$0.03

-34.4%

NASDAQ · Mkt cap $3.2 M

Nocera announced a 1-for-30 reverse stock split effective July 7, 2026, which typically signals financial distress or delisting risk and triggered a 34% single-day sell-off on the news.

The headline directly states that Nocera announced a 1-for-30 reverse stock split, with trading on a split-adjusted basis beginning July 7, 2026. Reverse splits of this magnitude are almost universally negative signals in equity markets. They are typically employed by companies facing NASDAQ minimum bid price requirements (usually $1 per share) to avoid delisting, or to restructure capital when a stock has deteriorated significantly. While the announcement frames this as part of advancing the company's "diversified technology strategy," investors interpreted the reverse split announcement as a red flag regarding financial viability, triggering immediate selling pressure. The stock's pre-split price of $0.07 was already deeply distressed, making the reverse split a desperation measure rather than a routine capital action. This structural event explains the sharp one-day decline.

JLHL

Julong Holding Limited Class A Ordinary SharesIndustrials

$7.33−$3.76

-33.9%

NASDAQ · Mkt cap $152 M

No news headlines were found in the last 48 hours, so the cause of the 33.90% drop cannot be directly attributed to a public announcement; the decline likely reflects either a delayed market reaction to earlier news, technical selling, or an undetected material event.

The complete absence of recent news in the search results makes it impossible to pinpoint a specific catalyst for JLHL's dramatic 33.90% single-day decline. For a stock dropping this sharply to the eighth-largest loser ranking, typical catalysts would include earnings disappointment, guidance reduction, regulatory setback, insider selling disclosure, analyst downgrade, or adverse sector news. Since none of these appear in the provided headlines, the move could reflect a delayed market repricing of earlier developments, technical breakdown of support levels, options expiration effects, or an event not yet captured in the Yahoo Finance RSS feed. Without access to the company's recent filings, earnings calendar, or broader news sources, the specific cause remains unknown.

SDOT

Sadot Group Inc.Consumer Defensive

$50.55−$21.45

-29.8%

NASDAQ · Mkt cap $11 M

No news headlines were found in the last 48 hours to explain SDOT's 29.79% drop on July 2, 2026, making the specific catalyst unclear without additional information.

A near-30% single-day loss for a NASDAQ-listed company would typically warrant significant news coverage, yet no headlines appear in the provided 48-hour window. This gap could indicate several scenarios: the catalyst may have been released before the 48-hour cutoff, the move may reflect delayed market reaction to an earlier announcement, or the sell-off could stem from technical factors, broader market conditions, or sector-specific headwinds not captured in the headlines provided. Without knowing SDOT's business model, recent earnings calendar, debt structure, or insider activity, it is difficult to narrow the cause further. Common drivers for moves of this magnitude include earnings misses, guidance cuts, SEC filings, executive departures, or short squeezes unwinding, but none are documented in the available news.

SONM

DNA X, Inc.Technology

$3.75−$1.51

-28.7%

NASDAQ · Mkt cap $3.2 M

No headlines were found in the last 48 hours to explain SONM's 28.71% drop, making the cause unclear without additional reporting or company announcements.

Despite the stock's position as the tenth biggest loser on July 2, 2026, no recent news headlines are available to identify a specific catalyst. For a biotech or life sciences company trading on NASDAQ under the symbol SONM (DNA X, Inc.), sharp single-day declines typically correlate with clinical trial results, regulatory setbacks, funding concerns, or guidance revisions. Without headline evidence, the decline could stem from delayed news that has not yet been indexed, technical selling following a recent run-up, broader sector weakness unrelated to company-specific events, or a smaller announcement not yet picked up by major financial news wires. The lack of transparency in available information makes definitive attribution impossible at this time.

JEM

707 Cayman Holdings Limited Ordinary SharesConsumer Cyclical

$2.30−$0.91

-28.3%

NASDAQ · Mkt cap $2.8 M

JEM dropped 28% on news that its crypto payment trial for apparel supply chains won't launch without regulatory permits from Hong Kong, EU, and FATF—a material delay to a key business initiative.

The July 1st headline reveals that 707 Cayman Holdings announced plans to integrate AI and blockchain into apparel supply chains, but critically stated it will not begin a crypto payment trial without regulatory approvals from Hong Kong's AMLO, the EU's MiCA, and the FATF Travel Rule compliance. This is a substantive conditional statement that introduces execution risk and indefinite timeline uncertainty to what appears to be a core growth strategy. Market participants likely interpreted the announcement as either overly optimistic messaging followed by regulatory reality-checking, or as a tacit admission that obtaining these permits is neither guaranteed nor imminent. The stock's 28% single-day decline suggests investors significantly repriced expectations for near-term revenue or operational progress from this blockchain initiative.

Jianzhi Education Technology Group Company LimitedTechnology

$0.10−$0.04

-28.1%

NASDAQ · Mkt cap $4.1 M

Jianzhi Education announced a plan to change its ADS ratio on July 1st, which typically signals a reverse stock split and often triggers sharp selloffs as investors worry about dilution, debt restructuring, or financial distress.

The company disclosed plans to implement an ADS ratio change, a corporate action that in practice often precedes or accompanies a reverse stock split. While the headline text is truncated and does not provide explicit details on the ratio or rationale, such announcements are generally viewed negatively by markets because they typically indicate the company is addressing financial weakness, stock price deterioration, or compliance issues rather than pursuing a favorable strategic transaction. The 28% single-day decline is consistent with acute negative sentiment following a reverse split announcement, particularly for a stock already trading at a very low price point of $0.10. Without more complete information on the specific ratio proposed or company guidance, the exact underlying driver remains partially obscured, but the timing and magnitude of the move align directly with the announcement date.

PFSA

Profusa, Inc. Common StockHealthcare

$0.09−$0.04

-28.1%

NASDAQ · Mkt cap $3.4 M

Profusa announced a 1-for-25 reverse stock split effective July 7, which triggered a 28% single-day sell-off. Reverse splits typically signal financial distress and dilution risk, driving immediate negative sentiment.

The headline directly attributes the crash to Profusa's announcement of a second reverse stock split within the same calendar year. Two reverse splits in one year is a red flag for investors, as it signals the company is struggling to maintain minimum listing standards and may indicate deteriorating financial health or burn rate concerns. Reverse splits mechanically combine shares to boost nominal share price but do not create value and often precede further dilution through capital raises. The market's sharp reaction reflects classic biotech behavior when facing operational or capitalization challenges. This is the second reverse split in 2026, which amplifies investor concern about runway and viability. The stock's current price of $0.09 after the move suggests it was trading near penny-stock levels prior to the announcement, consistent with a company in financial distress.

DXF

Eason Technology LimitedFinancial Services

$0.64−$0.24

-27.6%

AMEX · Mkt cap $1.6 M

DXF fell 27.56% on July 2, but the provided headlines offer no company-specific news; they only note that Asian ADRs as a group surged Thursday and edged lower Wednesday, offering no explanation for this particular stock's sharp decline.

The two headlines in the news feed discuss broad Asian ADR market movements (surging Thursday, edging lower Wednesday) but contain no information about Eason Technology Limited, its business, earnings, guidance, or any corporate event. The disconnect between the timing (headlines mention Thursday surge and Wednesday decline, yet DXF dropped 27.56% on Thursday July 2) and the lack of stock-specific detail makes these headlines unhelpful in explaining the move. For a penny stock like DXF trading at $0.64, typical catalysts for sharp single-day declines include reverse splits, dilutive financing announcements, insider selling, delisting warnings, or changes in market maker support. Without access to such information, the cause remains unidentified.

TERG

Leverage Shares 2X Long TER Daily ETF

$44.32−$15.88

-26.4%

NASDAQ

No news headlines were found in the last 48 hours. The 26.38% drop in this 2X leveraged ETF most likely reflects a sharp decline in the underlying TER stock or a broad market selloff on July 2, amplified by the fund's daily reset mechanics.

TERG is a 2X daily leveraged long ETF tracking TER (Teradyne). With no news provided in the 48-hour window, the cause of today's loss cannot be attributed to company-specific announcements. However, leveraged ETFs are structurally sensitive to market volatility and decay over time, especially during sharp daily moves. A decline of roughly 13% in the underlying TER stock would produce a 26% loss in a 2X leveraged fund before accounting for daily reset drag. The absence of headline coverage does not mean no catalyst exists—it means we lack information about what TER or the broader semiconductor sector experienced on or before July 2. The move likely stems from equity market stress, sector weakness, or company-specific news that did not surface in the RSS feed provided.

GVH

Globavend Holdings LimitedIndustrials

$4.45−$1.53

-25.6%

NASDAQ · Mkt cap $2.4 M

GVH dropped 25.59% on July 2, 2026 with no news headlines available in the prior 48 hours, making the underlying catalyst unclear and likely driven by an unannounced event, rumor, or technical factor.

No recent news headlines are available to explain this sharp 25.59% decline. Without a named catalyst such as earnings, regulatory action, guidance revision, or M&A announcement, the move must be attributed to other drivers. For a stock ranking 16th among daily losers, the most common explanations include undisclosed company announcements released after market hours or pre-market on July 2, a sector-wide selloff not captured in the headlines provided, short-seller activity or negative research, technical breakdown from support levels, or market rumors circulating outside of official channels. Globavend Holdings is not a widely followed mega-cap name, so retail or institutional flow shifts can move the stock more dramatically with less headline coverage than larger peers.

CIFG

Leverage Shares 2X Long CIFR Daily ETF

$8.94−$2.83

-24.0%

NASDAQ

No news headlines were found in the last 48 hours, but the stock is a 2X leveraged inverse ETF, so a -24% decline likely reflects a sharp rise in the underlying CIFR equity index or a broad market selloff in that space amplified by the leveraged structure.

Leverage Shares 2X Long CIFG is a daily leveraged ETF designed to deliver two times the daily return of its underlying index. Because no news was reported in the 48-hour window, the decline cannot be attributed to a company-specific event, earnings miss, or regulatory action. Instead, the move almost certainly stems from the underlying asset (CIFR) moving sharply higher, which would cause a long leveraged product to lose value proportionally. Alternatively, a broader market decline affecting the sector CIFR tracks could have compounded losses in a leveraged instrument. Without access to CIFR's price action or broader market data for July 2, 2026, we cannot pinpoint the exact catalyst, but leveraged ETFs are inherently sensitive to daily volatility and directional moves in their underlying benchmarks.

HKIT

Hitek Global Inc.Technology

$0.17−$0.05

-23.7%

NASDAQ · Mkt cap $27 M

Hitek announced a 1-for-25 reverse split effective July 1st, which typically depresses stock price in the short term as it signals financial distress and dilutes perception of share value despite maintaining market cap.

The reverse split announcement on July 1st aligns directly with the 23.72% drop on July 2nd. Reverse splits are generally perceived negatively by the market because they are associated with companies struggling to maintain minimum listing standards or attempting to reset shareholder psychology after prolonged weakness. While a reverse split mathematically preserves ownership percentages and total market capitalization, it often triggers selling pressure from retail investors who interpret the move as a red flag. The stock's position as the 18th biggest loser suggests the broader market reaction was severe. Without additional context about Hitek's financial condition, recent earnings, or the stated reason for the split, we cannot rule out that underlying operational challenges contributed to both the decision to reverse split and the market's negative reception. The timing between announcement and drop is consistent with reverse split mechanics.

ONTX

Onconova Therapeutics, Inc.Financial Services

$22.84−$6.91

-23.2%

EDBL

Edible Garden AG IncorporatedConsumer Defensive

$0.13−$0.04

-22.5%

NASDAQ · Mkt cap $1.8 M

No company-specific news was provided. EDBL's 22% drop appears driven by broad market weakness, as the only headline mentions US stocks opening lower due to employment data and Middle East developments.

The single headline supplied is a market-wide news item about broader equity weakness on Wednesday, July 1st, citing employment data missing forecasts and geopolitical concerns. There is no news directly about EDBL itself—no earnings release, guidance change, corporate action, or sector-specific development. EDBL is a small-cap greenhouse-farming company trading at $0.13, which makes it particularly vulnerable to broad market selloffs and sector rotation. Microcap stocks in the agriculture/food-tech space can also face pressure from commodity price swings, input cost inflation, or liquidity constraints, but none of those drivers appear in the available headlines. The timing and magnitude of the move suggest either participation in a broader market downturn or a delayed reaction to news not captured in the 48-hour window provided.

GLWG

Leverage Shares 2X Long GLW Daily ETF

$25.80−$7.26

-22.0%

NASDAQ

No news headlines were found in the last 48 hours, but GLWG is a 2X leveraged ETF tracking Corning Inc (GLW), so a sharp -21.96% decline most likely reflects a significant drop in the underlying stock, amplified by the fund's 2X daily leverage structure.

The absence of recent headlines makes direct attribution impossible, but GLWG's structure itself provides the explanation. As a 2X daily leverage ETF, this fund is designed to deliver twice the daily return of its underlying asset, Corning Inc (GLW). A -21.96% move in GLWG implies approximately a -11% move in GLW on this single day, which would be severe and warrant investigation into GLW-specific news such as earnings disappointment, guidance cut, industry headwinds, or major client loss. Without access to the underlying stock's intraday performance or news, we cannot confirm the precise catalyst, but leverage amplification accounts for why this ETF appears among the day's biggest losers. The timing snapshot of July 2, 2026, falls between US market holidays and mid-year reporting periods, so earnings or macro events are possible.

EHGO

Eshallgo Inc. Class A Ordinary SharesIndustrials

$2.08−$0.58

-21.8%

IREG

Leverage Shares 2x Long IREN Daily ETF

$9.27−$2.49

-21.2%

NASDAQ

No news headlines were found in the last 48 hours, but IREG is a 2x leveraged long ETF tracking IREN, so the 21% decline likely reflects a sharp drop in the underlying IREN stock amplified by the leverage factor.

The absence of any news in the headline feed makes it impossible to identify a specific catalyst for today's move. However, IREG's structure as a 2x leveraged daily ETF means it amplifies both gains and losses of its underlying security IREN by roughly double. A 21% decline in IREG would suggest approximately a 10-11% drop in IREN itself. Leveraged ETFs can also decline due to daily rebalancing decay over time, though this would typically manifest gradually rather than in a single large move. Without access to IREN-specific news or intraday price action, the most likely explanation is a sharp underlying sell-off in IREN, but the root cause of that move remains unknown from the information provided.

IRE

Defiance Daily Target 2X Long IREN ETF

$11.92−$3.17

-21.0%

AMEX

No news headlines were published in the last 48 hours, but the 21% decline in this 2X leveraged ETF tracking IREN stock likely reflects a sharp move in the underlying security, amplified by the fund's leverage structure.

The absence of recent news headlines makes direct attribution impossible. However, IRE is a daily reset 2X long leveraged ETF, which means it amplifies both gains and losses of its underlying holdings by approximately two times on a daily basis. A 21% decline in the ETF suggests the underlying IREN stock or index dropped roughly 10-11% on the day. Leveraged ETFs are sensitive to intraday volatility and decay over time, particularly during market stress. Without news, the underlying move could stem from sector rotation, broad market weakness, technical selling, options expiration effects, or an unannounced company development that has not yet appeared in Yahoo Finance feeds. The timing around July 2 also means holiday-adjacent lower liquidity could amplify moves.

UZX

Linkage Global Inc. Class A Ordinary SharesConsumer Cyclical

$0.27−$0.07

-21.0%

NASDAQ · Mkt cap $7.8 M

Linkage Global released first half 2026 financial results on June 30, likely disappointing the market enough to trigger a 21% single-day decline in UZX stock.

The only news in the provided headlines is Linkage Global's announcement of first half 2026 financial results issued on June 30, 2026, just two days before the observed price drop on July 2. The headline itself is truncated and contains no specific financial metrics, guidance changes, or commentary that would explain investor sentiment. However, the timing is highly suggestive: earnings announcements frequently drive sharp moves, and a 21% decline typically signals either a significant miss on revenue or profitability, disappointing forward guidance, or adverse business developments disclosed in the earnings release. Without access to the full earnings statement, the actual numbers, or management commentary, we cannot determine whether the miss was quantitative (lower-than-expected earnings per share or revenue) or qualitative (margin compression, market headwinds, or revised outlook). A cross-border e-commerce services company is sensitive to foreign exchange, tariff policy, and global trade trends, any of which could have deteriorated in the first half of 2026.

ALAR

Alarum Technologies Ltd.Technology

$6.35−$1.67

-20.8%

NASDAQ · Mkt cap $13 M

ALAR fell 20.82% on July 2 with no news reported in the last 48 hours, so the catalyst remains unclear; the drop may reflect profit-taking, a delayed announcement, or sector-wide pressure rather than company-specific news.

No headlines were available in the Yahoo Finance RSS feed for the last 48 hours surrounding this sharp 20.82% decline. This absence of reported news is notable given the size of the move and ALAR's rank as the 26th biggest loser of the day. Without documented catalysts such as earnings misses, executive departures, regulatory actions, or product setbacks, the underlying cause is speculative. Possible explanations include delayed news disclosure that has not yet propagated to major news aggregators, technical selling or margin calls in a smaller-cap name, sector rotation out of technology stocks, or a rumor circuit not yet captured by mainstream financial media. The disconnect between the magnitude of the move and the absence of breaking news suggests either that the trigger remains unreported, or that the stock is reactive to broader market conditions rather than company-specific events.

RGC

Regencell Bioscience Holdings LimitedHealthcare

$6.37−$1.66

-20.7%

NASDAQ · Mkt cap $2.9 B

No news headlines were found in the last 48 hours for RGC, so the 20.67% single-day drop likely reflects either a delayed market reaction to an untracked announcement, sector-wide biotech weakness, or technical selling pressure in a lower-volume microcap name.

The absence of recent news headlines makes it impossible to pin the decline to a specific catalyst such as clinical trial results, regulatory setbacks, or earnings disappointment. Regencell Bioscience is a small-cap biotech company, and stocks in this category are prone to sharp intraday moves driven by research updates, short-seller reports, sector rotation, or thin liquidity rather than broad market moves alone. The ranking as the 27th biggest loser suggests this was a notable move but not extreme on a market-wide basis. Without corroborating headlines or statements from the company, the most likely explanations fall into three categories: a delayed market reaction to news not yet indexed by the RSS feed, sector headwinds affecting biotech equities broadly on that date, or technical selling pressure accumulating in a low-float name. None of these can be confirmed from the data provided.

MRVU

Direxion Daily MRVL Bull 2X ETF

$152.01−$38.83

-20.3%

NASDAQ

No news headlines were published in the last 48 hours, but MRVU is a 2X leveraged bull ETF on Marvell Technology, so a significant drop in MRVL stock would be amplified approximately twofold in this fund, making a ~10% move in the underlying highly plausible as the root cause.

The absence of news in the Yahoo Finance RSS feed means we cannot identify a specific catalyst from headlines. However, MRVU is a leveraged ETF structure designed to deliver twice the daily returns of Marvell Technology (MRVL). A -20.35% decline in MRVU would correspond roughly to a -10% decline in MRVL itself, which is a material single-day move for a large-cap semiconductor stock. Possible drivers of such a move in the underlying could include sector-wide semiconductor weakness, company-specific operational news, or market-wide equity selloff, but without headlines or data on MRVL's price action we cannot confirm which. The leverage mechanism itself is not the cause of the drop, merely an amplifier of an underlying move.

MVLL

GraniteShares 2x Long MRVL Daily ETF

$37.93−$9.47

-20.0%

NASDAQ

MVLL, a 2x leveraged long ETF on Marvell Semiconductor, fell 19.98% on July 2, 2026, most likely due to a sharp decline in the underlying MRVL stock, which would be amplified roughly 2x by the fund's leverage structure.

The provided headline from July 1 celebrates strong performance of leveraged chip and AI ETFs in the first half of 2026, but contains no company-specific news about Marvell or any catalyst that would trigger a sudden 20% drop on July 2. MVLL's structure as a 2x daily leveraged ETF means it amplifies both gains and losses in its underlying stock approximately twofold. A roughly 10% decline in MRVL stock price would translate to approximately a 20% decline in MVLL. Without headlines reporting negative earnings, guidance cuts, competitive loss, or other adverse fundamental news about Marvell on July 1-2, the most likely explanations fall into general categories: broader semiconductor or AI sector weakness, a delayed negative announcement, technical profit-taking after the strong first-half run mentioned in the headline, or intraday volatility in chip stocks that disproportionately affected MRVL.

AIP

Arteris, Inc.Technology

$35.06−$8.75

-20.0%

NASDAQ · Mkt cap $1.0 B

No negative news is reported in the available headlines; the 20% drop on July 2 occurred despite recent positive licensing news and analyst optimism, suggesting the decline may reflect profit-taking after a 425% 52-week rally or unrelated market factors.

The two available headlines from the prior 48 hours are both constructive: SiEngine Technology licensed Arteris's NoC interconnect IP on July 1, and an analyst piece highlighted the stock's strong 425% gains and maintained a 100% Buy rating from Barchart. Neither headline contains negative guidance, missed earnings, contract cancellation, or any bearish catalyst. The timing of the drop—occurring after these bullish headlines were published—suggests the decline is either a technical reversal following extreme recent strength, a sector-wide pullback in semiconductors, profit-taking by momentum traders, or a response to an unreported announcement or market event that occurred on or after July 2 open. Without access to intraday news or the full market context on July 2, we cannot pinpoint the specific trigger.

XCH

XCHG Limited American Depositary ShareIndustrials

$0.57−$0.14

-19.3%

NASDAQ · Mkt cap $21 M

XCharge received a Nasdaq notice regarding failure to meet minimum bid price requirement, which typically triggers a delisting warning and prompted today's 19% selloff as investors react to regulatory jeopardy.

The June 30 headline confirms XCharge received a written notice from Nasdaq regarding the minimum bid price requirement, a regulatory compliance threshold that, if unmet within a specified cure period, can lead to delisting. This is a material corporate governance event that directly threatens the company's exchange listing status. The stock's sharp 19% decline on July 2 (two trading days after the announcement) reflects investor concern about potential delisting risk, loss of liquidity, and the reputational damage of failing to meet exchange standards. While the full terms of the notice are not detailed in the partial headline, Nasdaq notices of this type typically give companies 90 days to restore compliance, but the market often prices in significant risk premium immediately upon announcement. For a micro-cap stock trading at $0.57, a delisting threat is existential and typically justifies rapid repricing downward.

VICR

Vicor CorporationTechnology

$282.95−$67.26

-19.2%

NASDAQ · Mkt cap $8.7 B

Vicor Corporation dropped 19.21% on July 2, 2026, but no news headlines were available in the prior 48 hours to explain the sharp decline, suggesting either an unannounced catalyst, technical event, or delayed market reaction to unreported information.

No recent headlines are available to account for VICR's steep 19 percent single-day loss. Vicor is a semiconductor company specializing in power management and conversion technologies, serving data center, automotive, and industrial markets. For a stock of this type to fall nearly a fifth of its value intraday, typical catalysts include earnings misses or guidance cuts, supply chain disruptions, loss of a major customer or contract, competitive setbacks, analyst downgrades, or broader sector rotation out of semiconductor equities. Without news coverage in the relevant timeframe, the catalyst remains opaque. It is also possible that material information was announced before market open or after headlines were indexed, or that the move reflects accumulated technical selling or derivative-related unwinding rather than a fundamental event.

NBRGR

Newbridge Acquisition Limited Rights 2026-21.10.27 For Shares

$0.20−$0.05

-19.2%

NASDAQ

No news headlines were available in the last 48 hours to explain the 19.2% drop, so the decline likely reflects either technical selling pressure, expiration dynamics, or a delayed market reaction to an announcement not yet captured in RSS feeds.

The security is a SPAC rights offering expiring on 2026-10-27, a structure sensitive to time decay and redemption activity. With no recent news headlines available, the decline cannot be attributed to a specific company announcement, earnings miss, or named catalyst. Rights offerings typically experience pressure as expiration approaches if the underlying share price declines or if redemption activity increases. The lack of headline coverage suggests either that market participants were already pricing in decay dynamics, or that a material announcement occurred but has not yet propagated through Yahoo Finance RSS. Without access to broader financial newswires, regulatory filings, or SPAC-specific data, attributing this specific move requires inference about typical drivers of rights-based securities rather than documented fact.

ACLS

Axcelis Technologies, Inc.Technology

$144.50−$33.83

-19.0%

NASDAQ · Mkt cap $3.4 B

Axcelis Technologies dropped 18.97% on July 2, 2026, with no news headlines available in the prior 48 hours, making the exact trigger unclear but likely tied to earnings, guidance, or sector-wide weakness in semiconductor equipment.

No news headlines are available from the past 48 hours to directly explain the 18.97% decline in ACLS stock. This is a significant one-day loss for a company in the semiconductor capital equipment space. Possible drivers include an unannounced or delayed earnings report, negative preannouncement or guidance revision, weakness in ion implantation demand, deterioration in customer orders or backlog visibility, or broad sector weakness affecting semiconductor equipment manufacturers. Without contemporaneous headline evidence, the precise catalyst remains unknown. The magnitude of the drop suggests an material event such as an earnings miss, lowered guidance, or loss of a major customer or contract, but this is inference rather than established fact.

KUST

Kustom Entertainment, Inc.Communication Services

$1.08−$0.25

-18.8%

NASDAQ · Mkt cap $1.8 M

Kustom Entertainment fell 18.80% on positive news about record attendance at Country Stampede and a multi-season partnership deal, suggesting the market may have had different expectations or there are undisclosed negative developments offsetting the headlines.

The provided headline announces strong results: Country Stampede achieved 42,000+ attendees at its 30th anniversary and Kustom has secured a multi-season partnership with Gilley's Park City. These are typically positive developments for a live entertainment company. However, the stock dropped sharply on the same day the news was released. This disconnect suggests either the market had already priced in better expectations, the financial terms of the partnership are less favorable than initially hoped, or there is additional negative information not captured in the headline excerpt. Micro-cap entertainment stocks are also subject to high volatility and thin trading, which can amplify moves. Without fuller context on earnings, guidance, or debt levels, the precise cause remains unclear.

ARQQ

Arqit Quantum Inc.Technology

$23.52−$5.34

-18.5%

VECO

Veeco Instruments Inc.Technology

$57.49−$13.03

-18.5%

NASDAQ · Mkt cap $2.6 B

No VECO-specific news appeared in the 48-hour window; the 18.5% drop likely reflects sector weakness or a separate company event not captured in the provided headlines.

The only headline provided concerns KLA (KLAC), a semiconductor equipment peer, and addresses valuation multiples rather than a specific catalyst. The KLAC article mentions revenue growth expectations and forward multiples but does not announce earnings, guidance, or a sector-wide trigger. VECO and KLAC operate in overlapping equipment markets, so negative sentiment in the sector could spillover, but the KLAC headline does not establish a clear driver. A sharp single-day drop of this magnitude typically reflects earnings disappointment, guidance reduction, customer loss, or major competitive news. Without VECO-specific news in the record, the cause remains unknown; possible categories include unreported earnings or guidance, a customer announcement, or technical selling in a down day for semiconductor equipment stocks.

BRLS

Borealis Foods Inc.Consumer Defensive

$1.30−$0.29

-18.2%

NASDAQ · Mkt cap $19 M

Borealis Foods dropped 18.24% on July 2, 2026, but no news headlines are available in the last 48 hours to explain the move, leaving the catalyst unclear.

The absence of recent news headlines makes it difficult to pinpoint a specific cause for the 18% decline. For a small-cap food company trading near $1.30, typical catalysts would include earnings misses or disappointing guidance, regulatory setbacks, supply chain disruptions, management changes, or shifts in commodity prices affecting input costs. The stock's rank as the 38th biggest loser suggests this was a material single-day move rather than gradual deterioration. Without access to earnings announcements, regulatory filings, insider trading activity, or other corporate events, the underlying reason remains speculative. The move could reflect delayed dissemination of news to the RSS feed, a technical or sentiment-driven reversal, or an announcement made outside major news channels.

LCDL

GraniteShares 2x Long LCID Daily ETF

$0.73−$0.16

-18.1%

NASDAQ

No news emerged in the last 48 hours, but LCDL is a 2x leveraged ETF tracking Lucid Motors, so its 18% daily loss likely reflects a sharp decline in the underlying LCID stock, magnified by the fund's leverage structure.

Yahoo Finance reports zero headlines for LCDL in the past 48 hours, so no specific corporate or market event can be directly attributed to today's move based on news flow. However, LCDL's structure provides a strong explanatory framework: it is a daily rebalanced leveraged ETF that aims to deliver 2x the daily performance of Lucid Motors stock. A decline of roughly 9% in LCID would mechanically produce an 18% loss in LCDL, before accounting for rebalancing costs and decay. Lucid is a volatile EV manufacturer stock sensitive to demand concerns, capital raise announcements, production delays, or broader EV sector sentiment. Without headlines, the underlying catalyst for LCID's drop remains unknown, but leveraged ETF holders should expect amplified moves reflecting their underlying asset's performance.

FAMI

Farmmi, Inc.Consumer Defensive

$0.19−$0.04

-18.0%

NASDAQ · Mkt cap $3.9 M

No news headlines were available in the 48 hours before FAMI's 18% drop on July 2, 2026, so the specific catalyst cannot be determined from the evidence provided. The decline likely reflects technical selling, sector headwinds, or a delayed market reaction to undisclosed developments.

FAMI (Farmmi, Inc.) experienced a significant 18% intraday decline to $0.19 per share, ranking it among the day's 40 biggest losers. However, no news headlines appeared in Yahoo Finance's RSS feed within the 48 hours preceding this move. Without a documented catalyst, the decline could stem from several typical causes for a low-priced NASDAQ stock: accumulation of negative sentiment from prior weeks finally triggering institutional or algorithmic selling, a sector-wide downturn in agricultural or food-processing equities, short covering reversal, or a delayed market reaction to earnings or guidance misses announced earlier but not captured in the recent news feed. Technical breakdowns below key support levels can also trigger cascading selling in thinly traded microcaps. Given the stock's price point and trading profile, mechanical or sentiment-driven moves unaccompanied by fresh news headlines are not uncommon.

CRIS

Curis, Inc.Healthcare

$0.35−$0.08

-17.9%

NASDAQ · Mkt cap $4.2 M

No news headlines were found in the last 48 hours, so the 17.89% decline in CRIS cannot be directly attributed to a specific announced event; the drop likely stems from broader market weakness, technical selling, or unannounced developments.

Without recent headline coverage, the cause of CRIS's sharp decline remains unclear from publicly available news sources. Curis is a clinical-stage biopharmaceutical company, and stocks in this category are typically sensitive to clinical trial results, regulatory announcements, financing events, or shifts in pipeline valuation. The absence of news in the last 48 hours suggests either that the catalyst was not captured by the Yahoo Finance RSS feed, or that the sell-off was driven by technical factors such as sector rotation, short covering reversal, or reaction to older news that finally moved price. Given CRIS trades at $0.35 and ranks among the day's biggest losers, it is also possible that the move reflects margin pressure or forced liquidation in a thinly traded micro-cap security rather than fundamental news.

UCTT

Ultra Clean Holdings, Inc.Technology

$106.48−$23.12

-17.8%

NASDAQ · Mkt cap $3.0 B

No news headlines were found in the last 48 hours, so the 17.84% decline cannot be directly attributed to a reported event. The drop likely stems from sector weakness, a delayed earnings announcement, or technical selling in semiconductor equipment stocks.

Ultra Clean Holdings is a supplier of critical equipment and services to the semiconductor and display industries. A 17.84% single-day loss without accompanying news headlines is noteworthy and suggests either a catalyst that has not yet been widely reported, or a market-driven repricing. Possible explanations include: first, an earnings report released before market open or late the prior day that the Yahoo Finance RSS feed has not yet indexed; second, weakness in the semiconductor capital equipment sector broadly, driven by concerns about chip demand or fab spending cycles; third, commentary from a competitor or industry analyst that has reset expectations for the subsector. Without confirmatory headlines, the specific trigger remains unknown, but UCTT's business model makes it sensitive to semiconductor industry cycles and capex trends.

YDES

YD Bio Limited Ordinary SharesHealthcare

$1.90−$0.41

-17.7%

NASDAQ · Mkt cap $317 M

YD Bio announced expansion of its U.S. laboratory footprint to 46 states on July 2, but the stock fell 17.75% the same day, suggesting the market either view the expansion as capital-intensive without offsetting revenue catalysts or reacted to unrelated negative sentiment in biotech.

The only headline provided is a press release announcing YD Bio's expansion of DNA-methylation cancer detection operations across U.S. states. On its surface, geographic expansion of laboratory capacity and operational footprint would typically be viewed as a growth positive or at minimum a neutral operational milestone. However, the magnitude of the same-day 17.75% decline suggests either the market interpreted the expansion as requiring substantial capital expenditure that dilutes shareholder value, or the stock was hit by sector-wide biotech weakness, insider selling, or negative news not captured in the headlines provided. Without earnings data, financial guidance changes, or clinical setbacks in the announcement, the disconnect between the ostensibly bullish news and the sharp price action remains unexplained by the available evidence.

MOVE

Corvex, Inc.Technology

$17.37−$3.69

-17.5%

VIDA

VIDA Global Inc.Technology

$2.35−$0.49

-17.3%

AMEX · Mkt cap $46 M

No news headlines were found in the last 48 hours, so the 17.25% drop cannot be attributed to a specific announced catalyst. The decline is likely driven by technical selling, broader market sentiment, or undisclosed company developments.

The absence of any news in the Yahoo Finance RSS feed over the past two days means we cannot point to a specific earnings miss, regulatory action, guidance revision, or corporate announcement as the cause. For a microcap equity like VIDA trading on AMEX at $2.35, such sharp single-day moves are not uncommon and can be triggered by several categories of event: thin liquidity and momentum-driven selling, delayed disclosure of negative developments not yet in major feeds, sector-wide pressure affecting small-cap healthcare or biotech stocks, insider activity, or simple technical breakdown. Without access to press releases, SEC filings, or real-time market commentary, attributing the move to any specific catalyst would be speculation.

MXL

MaxLinear, Inc.Technology

$93.12−$19.27

-17.1%

NASDAQ · Mkt cap $6.3 B

MaxLinear fell 17.15% on July 2, 2026, but no news event on that date explains the drop. The only relevant headline is a July 1 announcement of an earnings call scheduled for July 23, which would not typically trigger an immediate sharp selloff.

The recent news provided contains only two items: a generic market commentary on July 2 about watching stock leaders, and a July 1 announcement that MaxLinear will hold an earnings call on July 23 to review Q2 2026 results. Neither headline directly explains a 17.15% single-day decline. The earnings call announcement itself is routine and forward-looking, not a disclosure of negative results or guidance. The timing gap between the announcement (July 1) and the call date (July 23) makes it unlikely the call announcement drove the drop on July 2. The decline may reflect broader semiconductor or tech sector weakness, a delayed market reaction to unreported news, technical selling, or short-covering unwind, but none of these can be confirmed from the headlines provided. Without earnings results, guidance revisions, contract losses, or other company-specific events reported, the specific catalyst remains unclear.

AEHR

Aehr Test SystemsTechnology

$69.96−$14.47

-17.1%

OUST

Ouster, Inc.Technology

$49.84−$10.18

-17.0%

NASDAQ · Mkt cap $2.6 B

Ouster announced a $200 million stock offering priced at $55.22 per share, a 10% discount to the prior close, triggering a selloff that continued to $49.84 as dilution concerns and negative sentiment overwhelmed positive news about BABA compliance for its Rev8 lidar sensors.

The 16.96% decline is primarily attributable to the equity offering announced on July 2nd. The company priced 3.62 million shares at $55.22, below the previous closing price of approximately $60.02, signaling dilution and prompting immediate negative reaction. The initial 7% drop from the announcement escalated further by day's close, suggesting either continued selling pressure from the offering itself or a shift in market sentiment. In parallel, Ouster released positive news on July 1st regarding BABA compliance for its Rev8 sensors, which opens access to federally funded U.S. infrastructure projects. However, this favorable development was insufficient to offset dilution concerns. The company also approved doubling authorized shares in June and announced an AIM Intelligent Machines deal, but these near-term positives were overwhelmed by the immediate capital-raising announcement and its equity-raise implications.

MEI

Methode Electronics, Inc.Technology

$15.30−$3.11

-16.9%

NYSE · Mkt cap $546 M

No news headlines were found in the last 48 hours to explain MEI's sharp 16.89% decline, so the trigger remains unknown without access to real-time market conditions or after-hours disclosures.

The absence of any recent news headlines is noteworthy given the severity of the one-day drop ranking MEI as the 49th largest loser on the exchange. Methode Electronics is an automotive and industrial electronics supplier, a sector sensitive to supply chain disruptions, automotive production cuts, and guidance revisions. Without news coverage, the decline could stem from several categories: an unannounced earnings miss or warning released outside normal trading hours, a significant contract loss or customer downgrades, sector-wide weakness in automotive stocks, technical selling or short covering, or a delayed market reaction to older information. The 16.89% magnitude suggests a material event rather than routine volatility, but without documented headlines or SEC filings in the provided data, pinpointing the catalyst requires speculation. Internal guidance, analyst downgrades, or supply chain announcements may have been disseminated through channels not captured in this 48-hour news window.

RFL

Rafael Holdings, Inc.Real Estate

$3.15−$0.63

-16.7%

NYSE · Mkt cap $94 M

No news headlines were found in the last 48 hours explaining Rafael Holdings' 16.67% drop on July 2, 2026, so the cause remains unclear from publicly available sources.

Rafael Holdings experienced a significant one-day decline of 16.67%, placing it among the day's largest losers, yet no recent news headlines are available to explain the move. This disconnect between price action and reported catalysts suggests several possible explanations. The drop could stem from a delayed market reaction to older news not captured in the 48-hour window, a private development or rumor circulating among investors, broader sector weakness affecting defense or aerospace companies (Rafael's typical business domain), technical selling pressure, or an earnings miss or guidance reduction announced after the news feed cutoff. Without specific information about Rafael's business segments, recent financial performance, or market conditions on that trading day, pinpointing the exact catalyst is not possible. Investors would need to consult earnings releases, SEC filings, or company statements from that date to identify the actual driver.